Who are the top shareholders of the Borosil Scienti.?

The top shareholder of Borosil Scienti is Kiran Kheruka, with a 25.53% stake. Promoters hold the majority of shares, while the highest public shareholder is the Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account at 2.23%.

The top shareholders of Borosil Scienti include Kiran Kheruka, who holds the highest promoter stake at 25.53%. The majority of the shares are held by promoters, with no pledged promoter holdings reported. Additionally, the highest public shareholder is the Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account, which holds 2.23%. Individual investors collectively own 22.88% of the shares, while mutual funds and foreign institutional investors hold minor stakes of 0.01% and 0.24%, respectively.

how big is Borosil Scienti.?

As of Jun 06, Borosil Scientific Ltd has a market capitalization of 1,228.00 Cr, with net sales of 437.74 Cr and a net profit of 26.80 Cr for the latest four quarters. The company has shareholder's funds of 375.90 Cr and total assets of 488.31 Cr as of the latest annual period ending in Mar'24.

Market Cap: As of Jun 06, Borosil Scientific Ltd has a market capitalization of 1,228.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Borosil Scientific Ltd reported net sales of 437.74 Cr and a net profit of 26.80 Cr. This data is consolidated.<BR><BR>Balance Sheet Snapshot: This is consolidated data for the latest annual period ending in Mar'24. The company has shareholder's funds amounting to 375.90 Cr and total assets of 488.31 Cr.

Has Borosil Scienti. declared dividend?

No Dividend History Available

Who are the peers of the Borosil Scienti.?

Borosil Scienti.'s peers include Timken India, SKF India, Grindwell Norton, and others, with varying management risks and growth rates. Sejal Glass shows excellent growth and the highest 1-year return at 56.73%, while Borosil Scienti. lacks a 1-year return for comparison.

Peers: The peers of Borosil Scienti. are Timken India, SKF India, Grindwell Norton, Carborundum Uni., Borosil Renew., Sejal Glass, Rubfila Intl., Harri. Malayalam, Galaxy Bearings, and Elgi Rubber Co.<BR><BR>Quality Snapshot: Excellent management risk is observed at SKF India and Rubfila Intl., while Good management risk is found at Timken India, Grindwell Norton, and Carborundum Uni. Below Average management risk is noted at Borosil Renew., Borosil Scienti., Sejal Glass, and Elgi Rubber Co., and Average management risk is present at Harri. Malayalam. All peers exhibit Below Average growth except for Sejal Glass, which has Excellent growth, while the rest show Below Average growth. Capital Structure is Excellent for Timken India, SKF India, Grindwell Norton, Carborundum Uni., Rubfila Intl., and Galaxy Bearings, Average for Borosil Renew., Below Average for Sejal Glass, Harri. Malayalam, Elgi Rubber Co., and Borosil Scienti.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sejal Glass at 56.73%, while the lowest is Grindwell Norton at -30.27%. Borosil Scienti. does not have a 1-year return available for comparison. Additionally, the six-month return is negative for Timken India, SKF India, Grindwell Norton, Carborundum Uni., and Elgi Rubber Co.

What does Borosil Scienti. do?

Borosil Scientific Ltd is a small-cap company in the industrial products sector, reporting net sales of 1,295 Cr and a net profit of 87 Cr for March 2025. Key metrics include a P/E of 42.00 and a market cap of INR 1,392 Cr.

Overview:<BR>Borosil Scientific Ltd operates in the industrial products sector and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated in 1991 under the name 'Klass Pack Private Limited'. The latest quarterly results report net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 1,295 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 87 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,392 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 42.00 <BR>Industry P/E: 45 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.01 <BR>Return on Equity: 8.79% <BR>Price to Book: 3.49 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

When is the next results date for Borosil Scienti.?

Borosil Scienti. will announce its results on 06 November 2025.

Borosil Scienti. will declare its results on 06 November 2025.

Are Borosil Scienti. latest results good or bad?

Borosil Scientific's latest Q2 FY26 results are poor, with a net loss of ₹4.16 crore and a 25.87% decline in net sales compared to the previous quarter. The significant drop in profitability and operating margins raises concerns about the company's sustainability and future performance.

Borosil Scientific's latest results for Q2 FY26 indicate a challenging quarter for the company. The net profit reported was a loss of ₹4.16 crore, which represents a significant decline of 147.98% compared to the previous quarter and a staggering 182.54% drop year-on-year. This marks one of the worst quarterly performances in recent history.<BR><BR>Net sales also fell sharply, declining by 25.87% from ₹129.48 crore in Q1 FY26 to ₹95.98 crore in Q2 FY26, and down 7.89% compared to the same quarter last year. The operating margin, excluding other income, dropped to just 5.08%, down from 12.79% in the previous quarter, indicating severe pressure on the company's core profitability.<BR><BR>Overall, the financial metrics suggest significant operational challenges and a deteriorating business model, raising concerns about sustainability and future performance. The company’s return on equity is well below industry standards at 6.63%, and the reliance on other income to support profitability is a structural concern. Given these factors, the latest results can be characterized as poor, reflecting a critical need for management to address these issues moving forward.

Is Borosil Scienti. overvalued or undervalued?

As of November 18, 2025, Borosil Scientific is considered overvalued with a PE ratio of 65.87 and has underperformed the Sensex, indicating it may be expensive compared to its peers despite being relatively more attractive than Borosil Renewables.

As of 18 November 2025, Borosil Scientific has moved from a fair to an expensive valuation grade. The company is currently considered overvalued, with a PE ratio of 65.87, an EV to EBITDA ratio of 27.83, and a Price to Book Value of 2.98. These ratios indicate that the stock is trading at a premium compared to its earnings and book value, suggesting a lack of justification for its current price level.<BR><BR>In comparison to its peers, Borosil Scientific's valuation appears high, especially when looking at Asahi India Glass, which has a PE ratio of 88, and Borosil Renewables, with a staggering PE of 216.85. While Borosil itself is categorized as expensive, it is relatively more attractive than its direct competitors like Borosil Renewables. Recent stock performance shows that Borosil has underperformed the Sensex over the past year, with a return of -22.18% compared to the Sensex's 9.48%, further reinforcing the notion that the stock may be overvalued at its current price of 135.60.

How has been the historical performance of Borosil Scienti.?

Borosil Scienti. showed positive financial growth from March 2024 to March 2025, with net sales increasing to 438.49 Cr, profit after tax rising to 26.72 Cr, and significant improvement in cash flow from operating activities to 120.00 Cr. Key metrics like earnings per share and operating profit margin also saw increases, indicating solid overall performance.

Answer:<BR>The historical performance of Borosil Scienti. shows a positive trend in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Borosil Scienti. reported net sales of 438.49 Cr in March 2025, an increase from 395.98 Cr in March 2024. The total operating income also rose to 438.49 Cr from 395.98 Cr, with raw material costs increasing to 143.54 Cr from 128.47 Cr, while the purchase of finished goods decreased slightly. Total expenditure, excluding depreciation, grew to 385.90 Cr from 349.30 Cr, leading to an operating profit (PBDIT) of 60.41 Cr, up from 50.70 Cr. Profit before tax improved to 40.39 Cr from 31.55 Cr, resulting in a profit after tax of 26.72 Cr compared to 23.48 Cr the previous year. The earnings per share increased to 3.01 from 2.65, and the operating profit margin rose to 11.99% from 11.79%. On the balance sheet, total liabilities increased to 504.34 Cr from 488.31 Cr, while total assets also grew to 504.34 Cr from 488.31 Cr. Cash flow from operating activities significantly improved to 120.00 Cr from 30.00 Cr, indicating a stronger cash position. Overall, Borosil Scienti. demonstrated growth in sales, profits, and cash flow, reflecting a solid financial performance over the year.

Should I buy, sell or hold Borosil Scienti.?

Is Borosil Scienti. technically bullish or bearish?

As of December 2, 2025, the technical trend has shifted to a bearish stance with moderate strength, supported by bearish MACD, moving averages, and Bollinger Bands, despite a mildly bullish OBV signal.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages also indicate a bearish trend. The Bollinger Bands on the weekly chart confirm this bearish outlook. Although the On-Balance Volume (OBV) shows a mildly bullish signal on the weekly timeframe, it is countered by the overall bearish indicators. The stock has underperformed significantly compared to the Sensex over multiple time frames, further supporting the bearish sentiment.

Which are the latest news on Borosil Scienti.?

Why is Borosil Scienti. falling/rising?

As of 03-Dec, Borosil Scientific Ltd's stock price is at 124.40, down 0.4%, and has declined 2.62% over the last two days. The stock has a year-to-date drop of 24.38% and is underperforming the Sensex, with concerns stemming from low profitability and disappointing financial results.

As of 03-Dec, Borosil Scientific Ltd's stock price is currently at 124.40, reflecting a decrease of 0.5, or 0.4%. The stock has been experiencing a downward trend, having fallen consecutively for the last two days, resulting in a total decline of 2.62% during this period. Over the past week, the stock has underperformed the benchmark Sensex, with a decline of 0.72% compared to the Sensex's 0.59% drop.<BR><BR>The stock's performance over the longer term is concerning, with a year-to-date decline of 24.38% and a one-year decline of 31.10%, significantly underperforming the Sensex, which has gained 8.92% and 5.27% respectively in the same periods. Additionally, the stock is trading below its moving averages across various time frames, indicating a bearish trend.<BR><BR>Factors contributing to the stock's decline include poor management efficiency, as evidenced by a low Return on Equity (ROE) of 4.53%, which signifies low profitability per unit of shareholders' funds. Furthermore, the company's net sales growth has been modest at an annual rate of 9.80%, with operating profit growth even lower at 2.86% over the past five years. Recent financial results have also been disappointing, with a significant drop in profit after tax (PAT) by 61.39% in the latest six months.<BR><BR>Investor sentiment appears to be cautious, as indicated by the low participation from domestic mutual funds, which hold only 0.04% of the company. This minimal stake may suggest a lack of confidence in the company's valuation and business prospects. Overall, the combination of poor short-term and long-term performance metrics, alongside negative financial results, is driving the stock's decline.